| Net Cash Provided by (Used in) Operating Activities |
$7,597,000 |
USD |
42% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$12,366,000 |
USD |
|
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$3,017,000 |
USD |
-104% |
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
15,000,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
8,416,145 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,752,000 |
USD |
-90% |
Q4 2024 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$38,890,000 |
USD |
1044% |
Q3 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$655,000 |
USD |
-64% |
Q4 2024 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$14,094,000 |
USD |
145% |
Q3 2025 |
FY 2025 |
| Operating Lease, Liability |
$164,000 |
USD |
-49% |
Q3 2025 |
FY 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$3,017,000 |
USD |
-14% |
Q4 2024 |
Q1 2025 |
| Lessee, Operating Lease, Liability, to be Paid |
$167,000 |
USD |
-50% |
Q3 2025 |
FY 2025 |
| Operating Lease, Liability, Current |
$150,000 |
USD |
-2% |
Q3 2025 |
FY 2025 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.05 |
pure |
0% |
Q3 2025 |
FY 2025 |
| Deferred Income Tax Expense (Benefit) |
$2,179,000 |
USD |
|
Q4 2024 |
Q1 2025 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$3,000 |
USD |
-75% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$11,377,000 |
USD |
149% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$176,639,000 |
USD |
1077% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$27,860,000 |
USD |
27% |
Q3 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$195,000 |
USD |
11% |
Q2 2025 |
Q3 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
FY 2025 |